Feihu Bai (Daya Zhang)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 27

Top Topics

Psychometric Properties

Endoscopic Submucosal Dissection

Helicobacter Pylori

Top Venues

Scientific reports

BMC gastroenterology

BMC infectious diseases

International journal of general medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Chen Chen, Da-Ya Zhang, Shiju Chen, Shimei Huang, Fan Zeng, Da Li, Yan-Ting Lv, Xiaohong Xiang, Run-Xiang Chen, Xiaodong Zhang, Fengjiao Mao, Xianfeng Huang, Jun Wang, Feihu Bai
Prevalence, types, and risk factors of functional gastrointestinal diseases in Hainan Province, China. Scientific reports 14 (1) (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Chen Chen, Da-Ya Zhang, Shiju Chen, Shimei Huang, Fan Zeng, Da Li, Yan-Ting Lv, Xiaohong Xiang, Run-Xiang Chen, Xiaodong Zhang, Fengjiao Mao, Xianfeng Huang, Jun Wang, Feihu Bai
Prevalence, types, and risk factors of functional gastrointestinal diseases in Hainan Province, China. Scientific reports 14 (1) (2024)
Chen Chen, Da-Ya Zhang, Shiju Chen, Shimei Huang, Fan Zeng, Da Li, Yan-Ting Lv, Xiaohong Xiang, Run-Xiang Chen, Xiaodong Zhang, Fengjiao Mao, Xianfeng Huang, Jun Wang, Feihu Bai
Prevalence, types, and risk factors of functional gastrointestinal diseases in Hainan Province, China. Scientific reports 14 (1) (2024)
Ling Zhang, Daya Zhang, Ling Wei, Yan Zhou, Ximei Li, Runxiang Chen, Xiaodong Zhang, Shiju Chen, Feihu Bai
H. pylori infection and osteoporosis: a large-scale observational and mendelian randomization study. BMC infectious diseases 24 (1) (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Run-Xiang Chen, Fengjiao Mao, Shimei Huang, Chen Chen, Da Li, Fan Zeng, Feihu Bai
Recurrence Rate and Influencing Factors of Helicobacter Pylori Infection After Successful Eradication in Southern Coastal China. International journal of general medicine 17 (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Publisher Correction: Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Ling Zhang, Daya Zhang, Ling Wei, Yan Zhou, Ximei Li, Runxiang Chen, Xiaodong Zhang, Shiju Chen, Feihu Bai
H. pylori infection and osteoporosis: a large-scale observational and mendelian randomization study. BMC infectious diseases 24 (1) (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Publisher Correction: Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Run-Xiang Chen, Fengjiao Mao, Shimei Huang, Chen Chen, Da Li, Fan Zeng, Feihu Bai
Recurrence Rate and Influencing Factors of Helicobacter Pylori Infection After Successful Eradication in Southern Coastal China. International journal of general medicine 17 (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Chen Chen, Daya Zhang, Shimei Huang, Fan Zeng, Da Li, Xiaodong Zhang, Runxiang Chen, Shiju Chen, Jun Wang, Feihu Bai
Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial. BMC gastroenterology 24 (1) (2024)
Chen Chen, Daya Zhang, Shimei Huang, Fan Zeng, Da Li, Xiaodong Zhang, Runxiang Chen, Shiju Chen, Jun Wang, Feihu Bai
Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial. BMC gastroenterology 24 (1) (2024)
Ling Zhang, Daya Zhang, Ling Wei, Yan Zhou, Ximei Li, Runxiang Chen, Xiaodong Zhang, Shiju Chen, Feihu Bai
H. pylori infection and osteoporosis: a large-scale observational and mendelian randomization study. BMC infectious diseases 24 (1) (2024)
Chen Chen, Daya Zhang, Shimei Huang, Fan Zeng, Da Li, Xiaodong Zhang, Runxiang Chen, Shiju Chen, Jun Wang, Feihu Bai
Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial. BMC gastroenterology 24 (1) (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Chen Chen, Daya Zhang, Shimei Huang, Fan Zeng, Da Li, Xiaodong Zhang, Runxiang Chen, Shiju Chen, Jun Wang, Feihu Bai
Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial. BMC gastroenterology 24 (1) (2024)
Xianfeng Huang, Da-Ya Zhang, Da Li, Yanting Lv, Shiju Chen, Feihu Bai
Human gastric microbiota analysis of refractory H. pylori infection. Scientific reports 14 (1) (2024)
Run-Xiang Chen, Da-Ya Zhang, Xiaodong Zhang, Shiju Chen, Shimei Huang, Chen Chen, Da Li, Fan Zeng, Jiajia Chen, Cuiyi Mo, Lei Gao, Juntao Zeng, Jianxin Xiong, Zhai Chen, Feihu Bai
A survey on Helicobacter pylori infection rate in Hainan Province and analysis of related risk factors. BMC gastroenterology 23 (1) (2023)
Feihu Bai, Run-Xiang Chen, Yunqian Xie, Fan Zeng, Shiju Chen, Runxiang Chen, Xiaodong Zhang, Shimei Huang, Da Li, Feihu Bai
Post-infection functional gastrointestinal disorders following coronavirus disease-19: a prospective follow-up cohort study. BMC infectious diseases 23 (1) (2023)
Zhen Yang, Yunqian Xie, Run-Xiang Chen, Yan Zou, Ximei Li, Runxiang Chen, Xiaodong Zhang, Shiju Chen, Feihu Bai
CYP2C19 gene polymorphism in Ningxia. Pharmacological reports : PR (2023)
Run-Xiang Chen, Lijun Zhang, Shiju Chen, Runxiang Chen, Xiaodong Zhang, Feihu Bai
Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital Staff. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Run-Xiang Chen, Lijun Zhang, Shiju Chen, Runxiang Chen, Xiaodong Zhang, Feihu Bai
Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital Staff. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Yan Zhou, Zishao Zhong, Shengjuan Hu, Jing Wang, Yanhong Deng, Ximei Li, Xianmei Chen, Xue Li, Yuanyuan Tang, Xiaofei Li, Qian Hao, Jun Liu, Tian Sang, Yang Bo, Feihu Bai
A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China. Antimicrobial agents and chemotherapy 66 (6) (2022)